|
Zh.A. Galeyeva, S.K. Zyryanov
Levofloxacin In The Treatment Of Community-acquired Pneumonia: Whether Advantages Are Obvious?
|
№5 / 2012
|
|
V.K. Tatochenko
Community-acquired Pneumonia In Children
|
№1 / 2012
|
|
L.I. Dvoretckiy’
Place Of Inhibitor-protected Penicillins In The Treatment Of Low Respiratory Tract Infections. Positions Remain Unchanged
|
№15 / 2011
|
|
A.I.Sinopalnikov
Community-acquired Pneumonia In Adults: Case Management Algorithms
|
№11 / 2011
|
|
Shapovalova T.G., Borisov I.M., Krainukov P.E., M.M. Shashina, Lekareva L.I.
The Role Of Systemic Enzyme Therapy In The Treatment Of Community-acquired Pneumonia Among Military Personnel
|
№4 / 2011
|
|
Nonikov V.E., Myshyakov V.I.
Levofloxacin (tavanic) In The Treatment Of Pneumonia
|
№4 / 2011
|
|
Geppe N.A., Dronov I.A.
Amoxicillin/clavulanate In The Treatment Of Infections Of Respiratory System And Ent-organs In Children: What Dose To Choose?
|
№1 / 2011
|
|
V. Nonikov
Antibacterial Therapy Of Community-acquired Pneumonia
|
№5 / 2010
|
|
A.Zaytsev
The Macrolides In Modern Algorithms Of Antibacterial Therapy Of Community-acquired Infections
|
№4 / 2010
|
|
S.B. Erofeeva С. 2024
Use Of Azithromycin (sumamed) In Therapeutical Practice
|
№19 / 2009
|
|
L.P. Djarkova
Azithromycin In The Treatment Of Out-patient Lower Respiratory Infections
|
№12 / 2009
|
Русский
